Skip to main content
OpenTrials

Clinical trial condition

Leukemia, B-Cell

Explore clinical trials studying Leukemia, B-Cell. Study availability and eligibility vary by location and protocol.

1,386 public trials 160 recruiting studies
Refine in advanced search Browse all conditions

Leukemia, B-Cell trial results

Active, Not Recruiting

Study of Acalabrutinib in Chinese Adult Subjects With Relapsed or Refractory Mantle Cell Lymphoma, Chronic Lymphocytic Leukemia or Other B-cell Malignancies

NCT03932331

Conditions
Chronic Disease, Disease Attributes, Hematologic Diseases, +19 more
Locations
  • Research Site Beijing, China
  • Research Site Beijing, China
  • Research Site Beijing, China
  • Research Site Changchun, China
View all 23 locations
View Trial Details
Active, Not Recruiting

NKX019, Intravenous Allogeneic Chimeric Antigen Receptor Natural Killer Cells (CAR NK), in Adults With B-cell Cancers

NCT05020678

Conditions
Aggressive Lymphoma, B-cell Acute Lymphoblastic Leukemia, Blood Protein Disorders, +43 more
Locations
  • Colorado Blood Cancer Institute Denver, Colorado, United States
  • The Cleveland Clinic Foundation Cleveland, Ohio, United States
  • Institute of Haematology, Royal Prince Alfred Hospital Camperdown, New South Wales, Australia
  • St. Vincent's Hospital Sydney, New South Wales, Australia
View Trial Details
Active, Not Recruiting

Long-Term Safety of Pirtobrutinib in Participants With Previously Treated Types of Blood Cancers

NCT07162181

Conditions
B-cell Lymphoma, Chronic Disease, Disease Attributes, +17 more
Locations
  • Beijing Cancer hospital Beijing, China
  • Sun Yat-sen University Cancer Center Guangzhou, China
  • Harbin Medical University Cancer Hospital Harbin, China
  • Shanghai East Hospital Shanghai, China
View Trial Details
Active, Not Recruiting

A Study of Ibrutinib + Obinutuzumab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia

NCT02537613

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +14 more
Locations
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • University of Rochester Wilmot Cancer Inst. Rochester, New York, United States
  • Duke University Medical Center Durham, North Carolina, United States
View Trial Details

Related conditions